Evidence map›Paper›PMID 37629761›Full record

ArticleMedicina (Kaunas, Lithuania)2023

The Prognostic Utility of the Metastatic Lymph Node Ratio and the Number of Regional Lymph Nodes Removed from Patients with Small Bowel Adenocarcinomas.

Dincer Aydin, Umut Kefeli, Melike Ozcelik, Gokmen Umut Erdem, Mehmet Ali Sendur, Mahmut Emre Yildirim, Basak Bala Oven, Ahmet Bilici, Mahmut Gumus

Abstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in Medicina (Kaunas, Lithuania), 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed.

  1. Article
  2. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors.

Dincer AydinDepartment of Medical Oncology, University of Health Sciences, Derince Training and Research Hospital, Kocaeli 41900, Turkey.
Umut KefeliDepartment of Medical Oncology, Faculty of Medicine, Kocaeli University, Kocaeli 41100, Turkey.
Melike OzcelikDepartment of Medical Oncology, University of Health Sciences, Umraniye Training and Research Hospital, Istanbul 34764, Turkey.
Gokmen Umut ErdemDepartment of Medical Oncology, University of Health Sciences, Cam and Sakura City Hospital, Istanbul 34480, Turkey.
Mehmet Ali SendurDepartment of Medical Oncology, University of Health Sciences, Ankara City Hospital, Ankara 06800, Turkey.
Mahmut Emre YildirimDepartment of Medical Oncology, University of Health Sciences, Kartal Dr. Lutfi Kirdar City Hospital, Istanbul 34865, Turkey.
Basak Bala OvenDepartment of Medical Oncology, Faculty of Medicine, Yeditepe University, Istanbul 34752, Turkey.
Ahmet BiliciDepartment of Medical Oncology, Faculty of Medicine, Medipol University, Istanbul 34214, Turkey.
Mahmut GumusDepartment of Medical Oncology, Faculty of Medicine, Medeniyet University, Istanbul 34722, Turkey.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Indexed as

AdenocarcinomaLymph Node RatioHumansLymphatic MetastasisLymph NodesPrognosisRetrospective Studieslymph node metastasismetastatic lymph node ratioprognosissmall bowel adenocarcinoma

Identifiers

PMID37629761
PMCPMC10456871

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.